Sat.Jul 31, 2021 - Fri.Aug 06, 2021

Even on social media “listen to the doctor”

World of DTC Marketing

SUMMARY : People are anxious because of the resurgence of COVID. Unfortunately, there is a lot of false and bad information online. To get accurate information, follow one of the many physicians online. They can provide answers based on science and their experience.

Prestige BioPharma’s Institutional Shareholders, Appreciate its High Growth Potential and Invest with a Long-term View

BioTech 365

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

In the absence of genetic variation, asexual invasive species find new methods of adapting to their environment

Scienmag

Gene 57

Thinking impaired in 60% of COVID-19 survivors

The Pharma Data

In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San Antonio reported July 29 at the Alzheimer’s Association International Conference.

Change of leadership is needed badly at the FDA and CDC

World of DTC Marketing

SUMMARY: It’s almost impossible for the average person to get accurate and reliable information from the media. Even vaccine booster shots are being debated by HCPs and Pfizer. We need to follow the science. Physiican trust in the FDA is decling as well.

Ixaka Appoints Laurent Audoly as a Non-Executive Director

BioTech 365

Ixaka Appoints Laurent Audoly as a Non-Executive Director Ixaka Appoints Laurent Audoly as a Non-Executive Director LONDON–(BUSINESS WIRE)–Ixaka Ltd, an integrated cell and gene therapy company focused on the natural power of the body to cure disease, today announces that … Continue reading → Business Wire

Drug Patent Expirations for the Week of August 1, 2021

Drug Patent Watch

BREO ELLIPTA (fluticasone furoate; vilanterol trifenatate) Glaxo grp ltd Patent: 6,537,983 Expiration: Aug 3, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business….

Drugs 52

More Trending

What All Clinical Research Sites Should Be Doing Right Now in 2021!

Clinical Trial Gurus

In a year like 2021 in clinical research, site owners and principal investigators should be positioning themselves to convert opportunities into positive outcomes. In this webinar we share some strategies for being able to successfully execute on this type of a year

Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders

BioTech 365

52

New patent expiration for Novadaq Tech drug SPY AGENT GREEN KIT

Drug Patent Watch

Annual Drug Patent Expirations for SPY+AGENT+GREEN+KIT Spy Agent Green Kit is a drug marketed by Novadaq Tech and is included in one NDA. It is available from one supplier. There….

Amgen Announces 2021 Third Quarter Dividend

The Pharma Data

Amgen today announced that its Board of Directors declared a $1.76 per share dividend for the third quarter of 2021. The dividend will be paid on September 8, 2021, to all stockholders of record as of the close of business on August 17, 2021.

BMS claims first EU okay for adjuvant oesophageal cancer immunotherapy

Pharma Phorum

Bristol-Myers Squibb is in a battle with Merck & Co for position in the upper gastrointestinal cancer immunotherapy market, and has just reinforced its position with an EU approval in the post-surgery (adjuvant) setting.

Sales 52

AMICOGEN Inc. and Lysando AG Bring Partnership to the Next Level With Ownership Participations in Each Other’s Companies

BioTech 365

AMICOGEN Inc. and Lysando AG Bring Partnership to the Next Level With Ownership Participations in Each Other’s Companies AMICOGEN Inc.

52

New patent expiration for Kastle Theraps drug KYNAMRO

Drug Patent Watch

Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are four patents protecting this drug. This drug…. The post New patent expiration for Kastle Theraps drug KYNAMRO appeared first on DrugPatentWatch - Make Better Decisions.

AbbVie Reports Second-Quarter 2021 Financial Results

The Pharma Data

Reports Second-Quarter Diluted EPS of $0.42 on a GAAP Basis; Adjusted Diluted EPS of $3.11 – Delivers Second-Quarter Net Revenues of $13.959 Billion, an Increase of 33.9

Botox 52

What Questions A Clinical Research Coordinator Can Ask The Job Interviewer During Interview

Clinical Trial Gurus

With so much emphasis understandably being placed on interview questions one may be asked during a clinical research coordinator job interview, I have never heard anyone discuss what questions the applicant should ask the interviewer. In this video I attempt to do exactly that

Leicester’s Hospitals Awards Deenova a Unit Dose Pharmacy Automation 15 Year Contract

BioTech 365

Drug Patent Expirations for the Week of August 1, 2021

Drug Patent Watch

TRELEGY ELLIPTA (fluticasone furoate; umeclidinium bromide; vilanterol trifenatate) Glaxosmithkline Patent: 6,759,398 Expiration: Aug 3, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…. The post Drug Patent Expirations for the Week of August 1, 2021 appeared first on DrugPatentWatch - Make Better Decisions. Patent Expiration

Drugs 40

Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie

The Pharma Data

– Takeda Intends to Challenge This Outcome through All Available Legal Means – First Quarter FY2021 Reported IRFS-based Financial Results Will Be Updated to Reflect the Impact of the Decision with No Impact on Core and Underlying Financial Results.

52

Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie

BioTech 365

Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie … Continue reading → Business Wire

52

AHF: ‘Providence Journal’ Rejects Ad Skewering CVS’s PBM Abuse

BioTech 365

AHF: ‘Providence Journal’ Rejects Ad Skewering CVS’s PBM Abuse AHF: ‘Providence Journal’ Rejects Ad Skewering CVS’s PBM Abuse AIDS organization’s ‘Corporate Vampires Suck’ advocacy ad had already run in nearly half-a-dozen print and online new outlets nationwide, but was rejected … Continue reading → Business Wire

52

Arete Pharmacy Network and Pharmacy Providers of Oklahoma Announce Successful Closing of Joint Venture to Form AlignRx

BioTech 365

Arete Pharmacy Network and Pharmacy Providers of Oklahoma Announce Successful Closing of Joint Venture to Form AlignRx Arete Pharmacy Network and Pharmacy Providers of Oklahoma Announce Successful Closing of Joint Venture to Form AlignRx Joint venture creates the largest independent … Continue reading → Business Wire

#news #biotech Abcam to acquire BioVision for $340m

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Abcam to acquire BioVision for $340m. from European Biotechnology – first and foremost in European biotech [link].

Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists

BioTech 365

Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists First Ever No-Code Platform Lowers Barriers to Automated Biological Experimentation and Insight … Continue reading → Business Wire

Cross Medical Group Introduces QWO® Injections for Cellulite Reduction

BioTech 365

Cross Medical Group Introduces QWO® Injections for Cellulite Reduction Cross Medical Group Introduces QWO® Injections for Cellulite Reduction Board-Certified Plastic Surgeon Dr. Kevin J. Cross and the Philadelphia-Based Team Now Offer the Leading-Edge Cellulite Treatment PHILADELPHIA, Aug. 02, 2021 (GLOBE … Continue reading → GlobeNewswire

40

Press news Biocartis Group NV: Update on Fire Incident at Biocartis Warehouse

BioTech 365

Press news Biocartis Group NV: Update on Fire Incident at Biocartis Warehouse Press news Biocartis Group NV: Update on Fire Incident at Biocartis Warehouse PRESS RELEASE 2 August 2021, 07:00 CET Update on Fire Incident at Biocartis Warehouse Mechelen, Belgium, … Continue reading → GlobeNewswire

40

Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translational Science

BioTech 365

Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translational Science Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translational Science Geneva, Switzerland, August 2, 2021 (GLOBE NEWSWIRE) – Ad Hoc Announcement Pursuant to Art. … Continue reading → GlobeNewswire

Addex Therapeutics to Release Half-Year 2021 Financial Results and Host Conference Call on August 5, 2021

BioTech 365

Addex Therapeutics to Release Half-Year 2021 Financial Results and Host Conference Call on August 5, 2021 Addex Therapeutics to Release Half-Year 2021 Financial Results and Host Conference Call on August 5, 2021 Geneva, Switzerland, August 2, 2021 – Addex Therapeutics Ltd … Continue reading → GlobeNewswire

40

GC Pharma Reports Q2 2021 Results

BioTech 365

GC Pharma Reports Q2 2021 Results GC Pharma Reports Q2 2021 Results YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months … Continue reading → Business Wire

40

IGEA PHARMA TO BOOST REVENUES ENTERING THE GROWING CANNABIS MARKET

BioTech 365

IGEA Pharma N.V. / Key word(s): Miscellaneous 02-Aug-2021 / 00:47 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. IGEA PHARMA TO BOOST REVENUES ENTERING THE … Continue reading → EQS Newsfeed

GC Pharma and Tottori University Enter Research Collaboration and License Agreement for Development of GM1 Gangliosidosis Chaperone Therapy

BioTech 365

GC Pharma and Tottori University Enter Research Collaboration and License Agreement for Development of GM1 Gangliosidosis Chaperone Therapy GC Pharma and Tottori University Enter Research Collaboration and License Agreement for Development of GM1 Gangliosidosis Chaperone Therapy – Collaboration aims to … Continue reading → Business Wire

Press news Biocartis Group NV: Fire Incident at Biocartis Warehouse in Mechelen, Belgium

BioTech 365

Press news Biocartis Group NV: Fire Incident at Biocartis Warehouse in Mechelen, Belgium Press news Biocartis Group NV: Fire Incident at Biocartis Warehouse in Mechelen, Belgium PRESS RELEASE 31 July 2021, 18:00 CET Fire Incident at Biocartis Warehouse … Continue reading → GlobeNewswire

40

Which pharmaceutical drugs have the most drug patents in Slovenia?

Drug Patent Watch

This chart shows the drugs with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Slovenia?

Drugs 52

Drugs facing the most patent expirations this year

Drug Patent Watch

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril….